Martin-Immanuel Bittner
Martin-Immanuel Bittner
Contributor, The Yuan

Martin-Immanuel Bittner is co-founder and chief executive at Arctoris, a drug discovery platform powered by robotics and data science. He has extensive research experience in both clinical trials and preclinical drug discovery.

AI, Robotics Team in Drug Discovery
The COVID-19 pandemic has highlighted more than ever the need for new treatments and drug discovery, which is generally a slow, expensive process that often ends in failure. Martin-Immanuel Bittner argues that previous problems will be overcome by combining robotics and data science, and richer, more reliable data can be generated at speed, enabling better decisions in both human-driven and computational drug discovery.
Martin-Immanuel Bittner  |  Oct 26, 2021